Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
| Status: | Archived |
|---|---|
| Conditions: | Breast Cancer, Colorectal Cancer, Ovarian Cancer, Cervical Cancer, Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | November 2008 |
A Phase IA, Multicenter, Open-label Dose Escalation Study of BKM120, Administered Orally in Adult Patients With Advanced Solid Malignancies
This is a first-in-man, phase I clinical research study with BKM120, a potent and highly
specific oral pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor. The study consists
of a dose escalation part followed by a MTD expansion part.
Once the MTD has been defined, the MTD expansion part will be opened for enrollment.
We found this trial at
2
sites
City of Hope Comprehensive Cancer Center City of Hope is a leading research and treatment...
Click here to add this to my saved trials
Sarah Cannon Cancer Center People who live with cancer
Click here to add this to my saved trials